Google
 
Web www.vitaminlore.com
www.eniva.com

Fenofibrate

Also indexed as: Tricor®

Fenofibrate is used to lower elevated cholesterol and triglyceride levels when diet, exercise, and weight loss programs are ineffective. It is in a family of medications known as cholesterol-lowering drugs.

Interactions with Dietary Supplements

Vitamin C and Vitamin E
Several studies have shown that fenofibrate enhances the toxic effect of ultraviolet (UV) radiation from the sun, which might result in side effects such as skin rashes. One controlled study showed that taking 2 grams of vitamin C and 1,000 IU of vitamin E prior to ultraviolet exposure dramatically blocked UV-fenofibrate damage to red blood cells.1 though further controlled studies are needed, people taking fenofibrate should probably supplement with vitamins C and E until more information is available.

Folic acid, Vitamin B6, and Vitamin B12
Increased blood levels of homocysteine are associated with increased risk of atherosclerosis and heart disease. One study revealed that fenofibrate dramatically increases blood homocysteine levels, though blood levels of vitamins were not reduced.2 Further research is needed to determine whether supplemental folic acid, vitamin B6, and vitamin B12 might lower fenofibrate-induced elevations in homocysteine blood levels.

Interactions with Foods and Other Compounds

Food
Taking fenofibrate together with food dramatically increases the absorption of the drug.3 Therefore fenofibrate should be taken with a meal.

Summary of Interactions for Fenofibrate

Depletion or interference None known
Adverse interaction None known
Side effect reduction/prevention Folic acid
Vitamin B12
Vitamin B6
Vitamin C
Vitamin E
Supportive interaction Food
Reduced drug absorption/bioavailability None known

For the convenience of the reader, the information in the summary is categorized as follows: “Depletion or interference” indicates the drug may deplete or interfere with the absorption or function of the supplement or herb. “Adverse interaction” indicates that the supplement or herb used together with the drug may result in undesirable effects. “Side effect reduction/prevention” indicates the supplement or herb may reduce the likelihood and/or severity of a potential side effect caused by the drug. “Supportive interaction” indicates the supplement or herb may support or aid the function of the drug. “Reduced drug absorption/bioavailability” indicates that the supplement or herb may decrease the absorption and/or activity of the drug in the body. An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.

References:

1. Eberlein-Konig B, Placzek M, Przybilla B. Phototoxic lysis of erythrocytes from humans is reduced after oral intake of ascorbic acid and d-alpha-tocopherol. Photodermatol Photoimmunol Photomed 1997;13:173–7.

2. Dierkes J, Westphal S, Luley C. Serum homocysteine increases after therapy with fenofibrate or bezafibrate. Lancet 1999;354:219–20.

3. Sifton DW, et. Physicians’ Desk Reference. Montvale, NJ: Medical Economics Company, Inc., 2000, 476–8.